New Webinar Available: The CRM Gamechanger

Thought Leadership

Stay in the know with content from industry experts.

Using AI to Predict Patient Drop-Off and Enhance Treatment Adherence

In the rapidly evolving landscape of healthcare, patient adherence to treatment plans remains a critical challenge. For patient access teams,…

Blog

Benchmarking Strategies for Pharmaceutical Product Launches

Launching a pharmaceutical product can resemble navigating a labyrinth. For market access teams, the stakes are high. Implementing a successful…

Blog

4 Essential KPIs for Gene Therapy Treatment

Gene therapy holds the promise to revolutionize medicine, particularly for patients with rare and genetic disorders. But how do patient…

Blog

How Emerging Technology is Transforming Medication Adherence

The Challenge of Medication Non-Adherence in Specialty Pharmacy Medication adherence refers to whether patients take their medications as prescribed, including…

Blog

Power of Biopharma Partnerships: GSK and Flagship Pioneering

Introduction In the fast-paced world of biopharma, partnerships can drive remarkable advancements. GlaxoSmithKline (GSK), a global healthcare leader, is taking…

Blog

Eli Lilly’s Urgent Push for Alzheimer’s Treatment Revolution

Introduction In the tough terrain of finding an Alzheimer’s cure, Eli Lilly is setting the pace with their latest innovation…

Blog

Pfizer’s Bold Move in the Obesity Drug Market

Within a sector populated by many market pioneers promoting injectable solutions, Pfizer is redefining the landscape with an oral medication…

Blog

Unlocking Competitive Data Insights in Therapy Basket Fill Rates

In the biopharma industry, understanding how your therapy basket’s fill rate stacks up against competitors can be a game-changer. This…

Blog

The Revolutionary Rise of Cell Therapy Trials

Picture a future in which we don’t merely manage symptoms but eliminate diseases at their roots. This future isn’t a…

Blog

AstraZeneca’s Calquence Sets New Standard for Lymphoma

Mantle cell lymphoma (MCL) is a rare yet aggressive form of non-Hodgkin lymphoma, and treatment options have been limited for…

Blog

FDA Draft Guidance: Fast-Track Cell and Gene Therapies

The FDA unveiled a much-anticipated draft guide, outlining how businesses can secure approvals for platform technologies. This regulatory advance has…

Blog

AstraZeneca Aims for $80 Billion Revenue by 2030

AstraZeneca is experiencing tremendous success and progress under the leadership of CEO Pascal Soriot. His current objective is to achieve…